Clinical trials recruiting for Advanced Solid Cancers
Fewer than 3 recruiting trials found.
2
Recruiting trials
3
US states with sites
6
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 2Phase 2 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| BNT329 | 1 |
| CA19-9-targeting monoclonal antibody | 1 |
| INV-6452 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Colorado | 1 |
| Florida | 1 |
| New York | 1 |
Top cities
Self-screener
Recruiting trials
- A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid Tumor
Related conditions
Trials recruiting for Advanced Solid Cancers often also study these conditions. Each links to its own recruiting-trial list.
Pancreatic cancer 870Ovarian cancer 118Endometrial cancer 68Colorectal cancer 1359Breast Cancer (Locally Advanced or Metastatic) 6Breast cancer 2239
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Advanced Solid Cancers trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.